Proton therapy reduces the effective dose to immune cells in breast cancer patients

EBCTCG (Early Breast Cancer Trialists’ Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F et al (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 21;383(9935):2127–2135 (Jun)

Article  Google Scholar 

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet. 2011 Nov 12;378(9804):1707–16.

Schmid P, Cortes J, Dent R, Pusztai L, McArthur H, Kümmel S et al (2022) Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer. N Engl J Med 10;386(6):556–567 (Feb)

Article  Google Scholar 

Zhao Y, Liu L, Weng L. Comparisons of Underlying Mechanisms, Clinical Efficacy and Safety Between Anti-PD‑1 and Anti-PD-L1 Immunotherapy: The State-of-the-Art Review and Future Perspectives. Frontiers in Pharmacology [Internet]. 2021 [cited 2023 Dec 23];12. Available from: https://www.frontiersin.org/articles/10.3389/fphar.2021.714483

Loap P, Kirova Y (2023) In Regard to Alcorn et al. Int J Radiat Oncol Biol Physics 1;116(2):469–470 (Jun)

Article  Google Scholar 

Xu C, Jin JY, Zhang M, Liu A, Wang J, Mohan R et al (2020) The Impact of the Effective Dose to Immune Cells on Lymphopenia and Survival of Esophageal Cancer after Chemoradiotherapy. Radiother Oncol 146:180–186 (May)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Friedes C, Iocolano M, Lee SH, Duan L, Li B, Doucette A et al (2024) The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC. Radiother Oncol 1;190:110030 (Jan)

Article  PubMed  Google Scholar 

Loap P, Kirov K, Kirova Y (2020) Cardiotoxicity in breast cancer patients treated with radiation therapy: From evidences to controversies. Crit Rev Oncol Hematol 156:103121

Article  PubMed  Google Scholar 

Loap P, Tkatchenko N, Goudjil F, Ribeiro M, Baron B, Fourquet A et al (2021) Cardiac substructure exposure in breast radiotherapy: a comparison between intensity modulated proton therapy and volumetric modulated arc therapy. Acta Oncol 31:1–7

Google Scholar 

Loap P, Beddok A, Cao KI, Goudjil F, Fourquet A, Dendale R et al (2021) Clinical practice of breast cancer protontherapy: A single-centre experience from selection to treatment. Cancer Radiother 3:

Loap P, Goudjil F, Servois V, Kirov K, Fourquet A, Kirova Y (2023) Radiation Exposure of Cardiac Conduction Nodes During Breast Proton Therapy. Int J Part Ther 9;10(1):59–64 (Mar)

Article  Google Scholar 

Vescovi JD, Zimmerman SL, Miller WC, Hildebrandt L, Hammer RL, Fernhall B (2001) Evaluation of the BOD POD for estimating percentage body fat in a heterogeneous group of adult humans. Eur J Appl Physiol 1;85(3):326–332 (Aug)

Article  PubMed  Google Scholar 

Bekelman JE, Lu H, Pugh S, Baker K, Berg CD, de Gonzalez AB et al (2019) Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol. Bmj Open 15;9(10):e25556 (Oct)

Article  Google Scholar 

Stick LB, Lorenzen EL, Yates ES, Anandadas C, Andersen K, Aristei C et al (2021) Selection criteria for early breast cancer patients in the DBCG proton trial—The randomised phase III trial strategy. Clinical and Translational Radiation. Oncology 1(27):126–131

Google Scholar 

Wang X, Bai H, Gao M, Guan Y, Yu L, Li J et al (2023) Impact of radiation dose to the immune system on disease progression and survival for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy. Radiother Oncol 186:109804 (Sep)

Article  PubMed  Google Scholar 

Mailhot Vega RB, Ishaq O, Raldow A, Perez CA, Jimenez R, Scherrer-Crosbie M et al (2016) Establishing Cost-Effective Allocation of Proton Therapy for Breast Irradiation. Int J Radiat Oncol Biol Phys 1;95(1):11–18 (May)

Article  PubMed  Google Scholar 

Kirova Y, Tallet A, Aznar MC, Loap P, Bouali A, Bourgier C (2020) Radio-induced cardiotoxicity: From physiopathology and risk factors to adaptation of radiotherapy treatment planning and recommended cardiac follow-up. Cancer Radiother 24(6-7):576–585 (Oct)

Article  CAS  PubMed  Google Scholar 

Celik E, Baus W, Baues C, Schröder W, Clivio A, Fogliata A et al (2020) Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer. Radiat Oncol 24;15(1):120 (May)

Article  PubMed  Google Scholar 

Sun T, Lin X, Tong Y, Liu X, Pan L, Tao C et al (2020) Heart and Cardiac Substructure Dose Sparing in Synchronous Bilateral Breast Radiotherapy: A Dosimetric Study of Proton and Photon Radiation Therapy. Front Oncol 9:1456

Article  PubMed  PubMed Central  Google Scholar 

Loap P, Tkatchenko N, Kirova Y (2020) Evaluation of a delineation software for cardiac atlas-based autosegmentation: An example of the use of artificial intelligence in modern radiotherapy. Cancer Radiother 24(8):826–833 (Dec)

Article  CAS  PubMed  Google Scholar 

Galts A, Hammi A (2024) FLASH radiotherapy sparing effect on the circulating lymphocytes in pencil beam scanning proton therapy: impact of hypofractionation and dose rate. Phys Med Biol 69(2):25006 (Jan)

Article  CAS  Google Scholar 

Hammi A, Paganetti H, Grassberger C (2020) 4D blood flow model for dose calculation to circulating blood and lymphocytes. Phys Med Biol 2;65(5):55008 (Mar)

Article  Google Scholar 

Aboudaram A, Loap P, Loirat D, Dhia SB, Cao K, Fourquet A et al (2021) Pertuzumab and trastuzumab combination with concomitant locoregional radiotherapy for the treatment of breast cancers with HER2 receptor overexpression. Cancers (Basel) 13(19):4790

Article  CAS  PubMed  Google Scholar 

Tison T, Loap P, Arnaud E, Cao K, Bringer S, Kissel M et al (2023) Tolerance of concurrent adjuvant radiotherapy and pembrolizumab for triple negative breast cancer: real life experience. Advances in Radiation. Oncology 17:101384

Google Scholar 

Loap P, Vu-Bezin J, Monceau V, Jacob S, Fourquet A, Kirova Y (2023) Dosimetric evaluation of the benefit of deep inspiration breath hold (DIBH) for locoregional irradiation of right breast cancer with volumetric modulated arctherapy (VMAT). Acta Oncol 62(2):150–158 (Feb)

Article  PubMed  Google Scholar 

Pandeli C, Smyth LML, David S, See AW (2019) Dose reduction to organs at risk with deep-inspiration breath-hold during right breast radiotherapy: a treatment planning study. Radiat Oncol 10;14(1):223 (Dec)

Article  Google Scholar 

留言 (0)

沒有登入
gif